Safety and Efficacy of the CRE8 Sirolimus-Eluting Stent for the Treatment of De Novo Coronary Artery Lesions

NCT02360709 · clinicaltrials.gov ↗

UNKNOWN

Status

800

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: CRE8 sirolimus-eluting stent

Sponsor

CID S.p.A.